By coupling an antitumor antibody fragment to an MHC molecule loaded with a viral peptide (i.e., CMV peptide) and coating the tumor with the complex, a tumor can resemble a virally infected cell, thus marking it for destruction by CVM-specific CD8+ T cells (Figure 4) [106–108]. Here, CD8A is linked to neoplasm.